Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis

BACKGROUND: Atherosclerosis is a chronic inflammatory disease responsible for most cases of heart disease and stroke in Western countries. The cytotoxic drug cyclophosphamide (CPA) can modulate immune functions, and it has therefore been used to treat patients with autoimmune diseases. Extension of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Cardiol Heart Vasc
Main Authors: Sato-Okabayashi, Yayoi, Isoda, Kikuo, Heissig, Beate, Kadoguchi, Tomoyasu, Akita, Koji, Kitamura, Kenichi, Shimada, Kazunori, Hattori, Koichi, Daida, Hiroyuki
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2020
Fag:
Original Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300380/
https://ncbi.nlm.nih.gov/pubmed/32577494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100529
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker